4//SEC Filing
Malady Kyle 4
Accession 0001093557-25-000253
CIK 0001093557other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:18 PM ET
Size
18.4 KB
Accession
0001093557-25-000253
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Malady Kyle
Director
Transactions
- Sale
Common Stock
2025-09-05$80.86/sh−667$53,934→ 22,667 total
Footnotes (2)
- [F1]On June 6, 2025, Mr. Malady adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Malady. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]Included in this number are 5,192 unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001760581
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:18 PM ET
- Size
- 18.4 KB